TG Therapeutics (TGTX) Alert: Johnson Fistel Investigates TG Therapeutics, Inc.; Investors Encouraged to Contact the Firm

SAN DIEGO, Sept. 26, 2018 /PRNewswire/ — Johnson Fistel, LLP, a shareholder rights law firm, is investigating potential claims on behalf of investors of TG Therapeutics, Inc. (NASDAQ: TGTX) (“TG Therapeutics”). TG Therapeutics is a biopharmaceutical company that focuses on the…

View more at https://www.prnewswire.com:443/news-releases/tg-therapeutics-tgtx-alert-johnson-fistel-investigates-tg-therapeutics-inc-investors-encouraged-to-contact-the-firm-300719000.html

No Comments

No comments yet.

Sorry, the comment form is closed at this time.